Suvratoxumab (MEDI4893) is a long-acting, high-affinity humanized monoclonal antibody against alpha-toxin, which can effectively neutralize the key virulence factor of Staphylococcus aureus (alpha-toxin), also can improve the survival rate and reduce lung injury in a mouse model of pneumonia with immunocompromise, and at the same time can enhance the antibacterial activity of Vancomycin or Linezolid.
Reinheit:
95.80%
CAS Nummer:
[1629620-18-3]
Target-Kategorie:
Antibacterial
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten